Evidence map›Paper›PMID 39225150›Full record

ArticleNanomedicine (London, England)2024

Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity.

Jacob A Medina, Debbie K Ledezma, Joshua Ghofrani, Jie Chen, Samantha J Chin, Preethi Bala Balakrishnan, Norman H Lee, Elizabeth E Sweeney, Rohan Fernandes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacob A MedinaIntegrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA.ORCID 0000-0001-9563-4994
Debbie K LedezmaIntegrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA.ORCID 0000-0001-7922-3773
Joshua GhofraniIntegrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA.ORCID 0000-0002-5956-9096
Jie ChenThe George Washington Cancer Center, George Washington University, WA 20052, USA.
Samantha J ChinIntegrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA.ORCID 0000-0002-1332-6873
Preethi Bala BalakrishnanThe George Washington Cancer Center, George Washington University, WA 20052, USA.ORCID 0000-0001-5576-7530
Norman H LeeIntegrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA.ORCID 0000-0003-4795-1420
Elizabeth E SweeneyThe George Washington Cancer Center, George Washington University, WA 20052, USA.ORCID 0000-0001-9202-3426
Rohan FernandesIntegrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA.ORCID 0000-0001-9439-4626

Funding

Engineered Ensemble Nanoimmunotherapies for CancerR37CA226171 · NCI · GEORGE WASHINGTON UNIVERSITY · PI FERNANDES, ROHAN · 2019 to 2024
$2.6M
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell TherapyR01CA290045 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI Conrad Russell Young Cruz, Rohan Fernandes · 2024 to 2026
$1.8M
National Cancer Institute, National Institutes of Health R37CA226171 and R01CA290045NCI NIH HHS R01 CA290045NCI NIH HHS R37 CA226171
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FerrocyanidesNanoparticlesPhotothermal TherapyTumor Necrosis Factor Receptor Superfamily, Member 9AnimalsCell Line, TumorHumansLiverMelanomaMelanoma, ExperimentalMiceferric ferrocyanideFerrocyanidesTumor Necrosis Factor Receptor Superfamily, Member 9anti-CD137combination immunotherapymelanomananoimmunotherapyphotothermal therapyPrussian blue nanoparticles

Identifiers

PMID39225150
PMCPMC11485692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.